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Commercially available high-resolution three-dimensional optical imaging modalities—including
confocal microscopy, two-photon microscopy, and optical coherence tomography—have fundamen-
tally impacted biomedicine. Unfortunately, such tools cannot penetrate biological tissue deeper than
the optical transport mean free path 1 mm in the skin. Photoacoustic tomography, which com-
bines strong optical contrast and high ultrasonic resolution in a single modality, has broken through
this fundamental depth limitation and achieved superdepth high-resolution optical imaging. In
parallel, radio frequency-or microwave-induced thermoacoustic tomography is being actively de-
veloped to combine radio frequency or microwave contrast with ultrasonic resolution. In this Vision
20 /20 article, the prospects of photoacoustic tomography are envisaged in the following aspects:
1 photoacoustic microscopy of optical absorption emerging as a mainstream technology, 2
melanoma detection using photoacoustic microscopy, 3 photoacoustic endoscopy, 4 simulta-
neous functional and molecular photoacoustic tomography, 5 photoacoustic tomography of gene
expression, 6 Doppler photoacoustic tomography for flow measurement, 7 photoacoustic tomog-
raphy of metabolic rate of oxygen, 8 photoacoustic mapping of sentinel lymph nodes, 9 multi-
scale photoacoustic imaging in vivo with common signal origins, 10 simultaneous photoacoustic
and thermoacoustic tomography of the breast, 11 photoacoustic and thermoacoustic tomography
of the brain, and 12 low-background thermoacoustic molecular imaging. © 2008 American As-
sociation of Physicists in Medicine. DOI: 10.1118/1.3013698
Key words: microscopy, melanoma detection, endoscopy, functional imaging, molecular imaging,
reporter gene imaging, Doppler effect, metabolic rate of oxygen, sentinel lymph nodes, multiscale
imaging, thermoacoustic tomography, breast imaging, brain imaging
I. INTRODUCTION
The field of photoacoustic tomography PAT has grown a
great deal in the past few years. PAT is cross-sectional or
three-dimensional imaging based on the photoacoustic effect.
Alexander Graham Bell first reported on the photoacoustic
effect in 1880. Only recently, however, was PAT developed
as an imaging technology.1–29 PAT combines high ultrasonic
resolution and strong optical contrast in a single modality,
capable of providing high-resolution structural, functional,19
and molecular30,31 imaging in vivo in optically scattering bio-
logical tissue at new depths.
In biological tissues, light transfer is dominated by scat-
tering. The mean free path is on the order of 0.1 mm, and the
transport mean free path is on the order of 1 mm. While the
former measures the frequency of predominantly anisotropic
scattering, the latter assesses the frequency of equivalent iso-
tropic scattering. As a result of scattering, photon propaga-
tion transitions from the ballistic regime into the diffusive
regime around one transport mean free path.4 Specifically,
the ballistic regime is within the mean free path, where a
significant number of photons have undergone no scattering.
The quasiballistic regime is from the mean free path to the
transport mean free path, where photons have sustained a
few scattering events but retain a strong memory of the origi-
nal incidence direction. The quasidiffusive regime is from
the transport mean free path to ten times the transport mean
free path, where photons have sustained many scattering
events and retain only a weak memory of the original inci-
dence direction. The diffusive regime is beyond ten times the
transport mean free path, where photons have suffered many
scattering events that they have almost completely lost their
memory of the original incidence direction.4
Two important depth limits exist for optical imaging. One
is near the optical transport mean free path, representing the
depth of the quasiballistic regime in biological tissue. Ballis-
tic light intensity attenuates exponentially with a decay con-
stant equal to the mean free path. To reach one transport
mean free path deep, photons must undergo significant scat-
tering, making focusing ineffective.32 We refer to this barrier
as the soft depth limit for high-resolution optical imaging.
Another depth limit is around 50–70 mm, which equals
roughly ten times the 1 /e optical penetration depth the re-
ciprocal of the effective attenuation coefficient. To reach
this depth, light must experience 43 dB or 20 000 times one-
way decay in intensity. Beyond this limit, even diffuse pho-
tons are too few for practical purposes. We refer to this limit
as the hard depth limit for optical imaging. Nevertheless, if
the tissue is illuminated from opposite sides, a thickness
greater than 10 cm can be potentially covered, which is ad-
equate for many biomedical applications such as breast im-
aging.
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High-resolution optical imaging beyond the soft depth
limit, sometimes referred to as superdepth optical imaging,
remained a void until PAT was developed. None of the com-
mercially available optical ballistic imaging modalities—
including confocal microscopy, two-photon microscopy and
optical coherence tomography—can penetrate into scattering
biological tissue beyond the soft depth limit. By contrast,
diffuse optical tomography—based on multiple-scattered
photons—can provide rapid functional and molecular imag-
ing beyond the soft depth limit; however, it has poor spatial
resolution. The motivation driving the development of PAT is
to overcome the poor spatial resolution of diffuse optical
tomography or the soft depth limit of existing high-
resolution optical imaging.
An approach to overcome the optical hard depth limit is to
adopt radiofrequency or microwaves for photoacoustic
excitation.6,7 In this case, the technology is referred to as
radio frequency- or microwave-induced acoustic tomography
or thermoacoustic tomography TAT. For simplicity here,
radio frequency refers to microwaves as well. In TAT, a radio
frequency generator instead of a laser is used. The radio
frequency generator transmits radio frequency pulses into the
tissue to be imaged. Radio frequency absorption produces
heat and subsequent ultrasonic waves. The ultrasound detec-
tion and image formation are similar to those in PAT.
Both PAT and TAT are designed to overcome the poor
spatial resolution of pure optical or radio frequency imaging
yet to retain the high electromagnetic contrasts. In terms of
spatial resolution, pure optical imaging beyond the soft depth
limit suffers from strong diffusion due to tissue scattering,
whereas pure radio frequency imaging suffers from strong
diffraction due to the long wavelength. Ultrasonic scattering
coefficient in tissue is 2–3 orders of magnitude less than the
optical counterpart, and the acoustic diffraction or wave-
length is 2–3 orders of magnitude weaker or shorter than
the radio frequency counterpart. As a result, PAT and TAT
can provide high spatial resolution by detecting the induced
ultrasonic waves. Unlike ultrasonography or optical coher-
ence tomography, PAT and TAT produce speckle-free
images.
The subsequent sections are organized as follows. First,
the basic principle of PAT is reviewed. Then, the future pros-
pects of PAT and TAT are envisioned on twelve specific top-
ics. Finally, a summary is provided.
II. BASICS OF PHOTOACOUSTIC TOMOGRAPHY
PAT involves optical irradiation, ultrasonic detection, and
image formation. The tissue is usually irradiated by a short-
pulsed laser beam to produce thermal and acoustic impulse
responses. Locally absorbed light is converted into heat,
which is further converted to a pressure rise via thermoelas-
tic expansion of the tissue. The initial pressure rise—
determined by the local optical energy deposition also called
specific optical absorption in the unit of J /m3 and other
thermal and mechanical properties—propagates in the tissue
as an ultrasonic wave, which is referred to as a photoacoustic
wave. The photoacoustic wave is detected by ultrasonic
transducers placed outside the tissue, producing electric sig-
nals. The electric signals are then amplified, digitized, and
transferred to a computer, where an image is formed. PAT
depends on any absorbed photons, either unscattered or scat-
tered, to produce photoacoustic signals as long as the photon
excitation is relaxed thermally. Readers are referred to recent
review and tutorial articles for more details.1,4
The formation of a photoacoustic image, mapping the
photoacoustic source according to the detected sound sig-
nals, can be exemplified with the simplest case of pinpoint-
ing a single sound source such as thunder in three-
dimensional 3D space. If the time delay between seeing
lightening and hearing thunder is recorded, one can infer that
the thunder took place on a spherical surface of a radius
determined by the product of the speed of sound and the time
delay. If three such measurements are taken at different lo-
cations, the sound source can be accurately triangulated. If
produced by the photoacoustic effect, the sound source can
be imaged by PAT. In most practical cases, the sound source
is spatially distributed rather than localized at a point.
PAT has been implemented in two major forms. One form
is based on a scanning focused ultrasonic transducer. Acous-
tic focusing in combination with time-resolved detection of
photoacoustic waves directly provides 3D spatial resolution.
Scanning over the tissue produces tomographic images.
Dark-field confocal photoacoustic microscopy belongs to
this category.33–35 Dark field means that the light illumination
pattern on the tissue surface is donut shaped with a dark
core; confocal means that the ultrasonic detection shares the
same focus as the light illumination. The other form is based
on an array of unfocused ultrasonic transducers. This
method, also referred to as photoacoustic computed tomog-
raphy, requires the use of an inverse algorithm to reconstruct
a tomographic image.36
The dominant contrast of interest is based on the optical
absorption in the photoacoustic excitation phase. By using
multiwavelength measurement, one can simultaneously
quantify concentrations of multiple chromophores of differ-
ent colors, such as oxygenated and deoxygenated hemoglo-
bin molecules in red blood cells. Such quantification of he-
moglobin can provide functional imaging of the
concentration and oxygen saturation of hemoglobin. Both
parameters are related to hallmarks of cancer: the concentra-
tion of hemoglobin correlates with angiogenesis,27 whereas
the oxygen saturation of hemoglobin correlates with
hypermetabolism.31 Such parameters of hemoglobin can also
be used to image brain activity.19 In addition, extrinsic opti-
cal absorption contrast agents can be used to provide mo-
lecular imaging of biomarkers.30,31
PAT is highly sensitive to optical absorption. PAT works
on dark background—when no absorption exists, the back-
ground signal is zero. Such dark background enables sensi-
tive detection. In the presence of absorption, the foreground
signal is proportional to the absorption coefficient. Any small
fractional change in optical absorption coefficient translates
into an equal amount of fractional change in PAT signal,
which means a relative sensitivity of 100%.2 When the frac-
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tional change is large, light transport modeling can be used
to quantify the optical absorption coefficient.37
The spatial resolution is derived from ultrasonic detection
in the photoacoustic emission phase. Ultrasonic scattering is
much weaker than optical scattering. The wavelength of the
detected photoacoustic wave is sufficiently short. As a result,
photoacoustic waves provide better resolution than optical
waves beyond the soft depth limit. Among other parameters,
the center frequency and the bandwidth of the ultrasonic de-
tection system predominantly determine the spatial reso-
lution of PAT. The greater the center frequency and the wider
the bandwidth, the better the spatial resolution is.
III. PREDICTIONS
III.A. Photoacoustic microscopy of optical absorption
going mainstream
Prediction 1: Photoacoustic microscopy will join the suite
of mainstream optical microscopy technologies.
Photoacoustic microscopy PAM has shown the follow-
ing capabilities. First, PAM has broken through the current
fundamental depth limitation of high-resolution optical im-
aging modalities.33,34 The commercially available micro-
scopic optical imaging modalities—including confocal mi-
croscopy, two-photon microscopy, and optical coherence
tomography—cannot provide penetration into scattering bio-
logical tissue beyond the soft depth limit 1 mm in the
skin because they are based on ballistic and quasiballistic
photons. Taking advantage of photons that have been scat-
tered an any number of times, PAM has filled the void of
penetration and reached superdepth optical imaging. As will
be shown in Sec. III A, imaging depths of 3–30 mm have
been experimentally demonstrated. Second, the depth-to-
resolution ratio maximum imaging depth divided by the
axial resolution can be approximately maintained at more
than 100 while the imaging depth and spatial resolution are
scaled. Third, PAM provides functional imaging based on
physiologically specific endogenous optical absorption con-
trasts. The red color in Fig. 1 shows a PAM image of blood
vasculature using endogenous contrast only, the contrast be-
tween the blood and the background is as high as 13:1.34 In
comparison, other imaging modalities such as x-ray com-
puted tomography and magnetic resonance imaging usually
require the use of exogenous contrast agents to image blood
vessels clearly with high contrast. Further, magnetic reso-
nance imaging cannot measure the concentration of hemo-
globin and the absolute oxygenation of hemoglobin. Fourth,
PAM can provide molecular or genetic imaging based on
exogenous contrast mechanisms.30,31 Fifth, PAM can be con-
structed to image in real time. A B-scan frame rate of 50 Hz
has been achieved.38,39 Sixth, PAM images are free of
speckle artifacts. Finally, PAM is safe to human subjects and
ready for clinical applications.
The various high-resolution optical imaging modalities
are compared in Table I. While PAM is sensitive to optical
absorption, it is insensitive to optical scattering or
fluorescence.2 The various modalities complement each other
in both penetration and contrast; they will therefore coexist.
In light of its appealing capabilities, PAM is expected to
become commercially available and widely used in biomedi-
cal research and clinical practice.
III.B. Melanoma detection using photoacoustic
microscopy
Prediction 2: Melanoma detection will become a high im-
pact application of photoacoustic microscopy.
While melanoma is the most deadly form of skin cancer,
it is curable if detected early. The diagnosis of melanoma is
often based on its appearance. Abnormally appearing skin
lesions are resected for biopsy. Because visual inspection is
inaccurate and biopsy is invasive, an accurate noninvasive
method of melanoma detection is desirable.
PAM can acquire 1 structural images measuring tumor
burden and depth, 2 functional images of hemoglobin con-
centration measuring tumor angiogenesis—a hallmark of
cancer, 3 functional images of hemoglobin oxygen satura-
tion SO2 measuring tumor hypoxia or hypermetabolism—
another hallmark of cancer, and 4 images of melanin con-
centration measuring tumor pigmentation—a hallmark of
melanotic melanoma, consisting of 90% of melanomas
note that even amelanotic melanoma contains a low concen-
tration of melanin. An in vivo PAM image of a melanoma in
a small animal is shown in Fig. 1. The depth of melanoma,
also an important prognostic parameter, was measured by
PAM. By contrast, other high-resolution optical microscopy
technologies cannot provide the required penetration. Be-
cause of biological variability in most biological problems, a
FIG. 1. a Photograph of a melanoma in a nude mouse; b image acquired
with the 50-MHz photoacoustic microscope operating at 584 and 764 nm.
Composite of the two maximum amplitude projection MAP images pro-
jected along the z axis. Six orders of vessel branching 1–6 can be ob-
served. c 3D rendering of the melanoma image acquired at 764 nm. Two
MAP images at this wavelength projected along the x and y axes are shown
on the sidewalls. The composite image in panel b is redrawn at the bottom.
The top of the tumor is 0.32 mm below the skin surface, and the thickness of
the tumor is 0.3 mm. d Close-up two-dimensional image of the melanoma
in a cross-section parallel with the z-x plane at the dashed line in panel b. e
HE-stained histological section at the same marked location. M: melanoma.
Reproduced with permission Fig. 2 of Ref. 34.
5760 Lihong V. Wang: Prospects of photoacoustic tomography 5760
Medical Physics, Vol. 35, No. 12, December 2008
single biomarker is unlikely able to provide accurate diagno-
sis. However, the combination of four complementary mea-
sures can significantly enhance the likelihood of high accu-
racy. In addition, as Doppler photoacoustic microscopy
matures, blood flow measurement can add more diagnostic
information. Therefore, it is expected that the combined rich
contrasts will provide the sensitivity and specificity needed
for the early detection of melanoma.
III.C. Photoacoustic endoscopy
Prediction 3: Photoacoustic endoscopy will play a unique
role in diagnosing gastrointestinal cancer.
Incidence of gastrointestinal cancer is on the rise yet often
diagnosed at an untreatable stage. Optical endoscopy is the
current practice in identifying suspicious lesions for subse-
quent biopsy. Operating in the mode of surface or ballistic
imaging, existing optical endoscopy has severely limited
penetration. Ultrasound endoscopy is being introduced into
the clinic as well. Yet the mechanical contrast in ultrasound
images often cannot provide the required sensitivity and
specificity. Other medical imaging modalities such as x-ray
computed tomography and magnetic resonance imaging have
not been implemented endoscopically because of diagnostic
insensitivity, technological difficulties or expenses.
Light and sound are well suited for endoscopic applica-
tions. Because both forms of energy have been used endo-
scopically, PAM can naturally be implemented endoscopi-
cally. As PAM can provide a multitude of endogenous
contrasts at new depths, it is likely to provide accurate diag-
nosis of superficial as well as deep lesions in the gastrointes-
tinal tract. Similarly, intravascular photoacoustic imaging can
also be implemented.40 Of course, adding molecular imaging
capability to photoacoustic endoscopy can further enhance
the diagnostic accuracy albeit at the inconvenience of using
exogenous contrast agent.
III.D. Simultaneous functional and molecular
photoacoustic tomography
Prediction 4: Simultaneous functional and molecular pho-
toacoustic tomography will provide unprecedented sensitiv-
ity and specificity to cancer diagnosis.
While functional imaging is based on endogenous con-
trast, molecular imaging is based on exogenous contrast—
which essentially stains invisible biomarkers in vivo. The
former maps physiological activities at the tissue or organ
level, whereas the latter images biological and pathophysi-
ological processes at the molecular level. Both can be ac-
complished quantitatively and noninvasively—with the ex-
ception of introducing exogenous contrast agent. By
combining imaging physics with molecular and cell biology,
molecular imaging can potentially lead to better methods for
preventing, diagnosing, and managing diseases. For ex-
ample, tumor biology and angiogenesis can be characterized
with high specificity because molecular imaging probes can
be designed to target at specific molecular biomarkers ex-
pressed on neoendothelial-and tumor-cell surfaces. Such
characterization will accelerate the development of
molecular-targeted cancer therapeutics. Nevertheless, mo-
lecular imaging will not supplant functional imaging. The
former requires the use of foreign contrast agent, whereas the
latter depends on intrinsic contrast only. Therefore, the
former may involve some degree of toxicity and may not be
universally applicable. In addition, functional imaging can
measure some physiological parameters that cannot be easily
measured by molecular imaging.
Simultaneous functional and molecular PAT was demon-
strated in live mice Fig. 2.31 One million human U87 glio-
blastoma tumor cells were implanted stereotactically into
young adult immunocompromised nude mice in the head
3 mm below the scalp surface. One week post inoculation,
20 nmol of molecular imaging probe IRDye800-cKRGDf
was administered through the tail vein while mannitol was
used to permeabilize the blood brain barrier. Approximately
20 h later, imaging with PAT was conducted. Four laser
wavelengths—764, 784, 804, and 824 nm—were used to
measure the spectral distribution of optical absorption due to
oxyhemoglobin, deoxyhemoglobin, and IRDye800-
cKRGDf. Figure 2a shows an in vivo pseudocolor func-
tional PAT image of the oxygen saturation of hemoglobin. A
focal region pointed by the arrow shows lower oxygen satu-
TABLE I. Comparison of high-resolution optical imaging modalities.
Modality Penetration Primary contrast
Confocal microscopy 0.5 mm Scattering, fluorescence
Two-photon microscopy 0.5 mm Fluorescence
Optical coherence tomography 1 mm Scattering, polarization
Photoacoustic microscopy Up to 30 mm, scalable Absorption
FIG. 2. a In vivo functional PAT image of hemoglobin in a nude mouse
brain with a U87 glioblastoma xenograft. The arrow indicates the hypoxic
region. b In vivo molecular PAT image of tail-vein injected IRDye800-
cKRGDf in the same nude mouse brain. The circle indicates the region of
integrin overexpression. Reproduced with permission Figs. 2 and 3 of
Ref. 31.
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ration of hemoglobin than the surrounding area, indicating
hypoxia characteristic of tumor due to hypermetabolism.
Figure 2b shows an in vivo pseudocolor molecular PAT
image of the molecular imaging probe. Integrin v3 is
known to overexpress in U87 glioblastoma tumors while
IRDye800-cKRGDf is known to bind to v3 integrin. The
circled region indicates the overexpression of integrin in the
U87 glioblastoma tumor. The focal regions of both the func-
tional and molecular contrasts were corroborated to be the
tumor region through postmortem fluorescence imaging and
histological examination.
PAT is competitive in sensitivity compared with other ex-
isting molecular imaging technologies. In comparison to the
nM–pM sensitivity of positron emission tomography at mm
spatial resolution, PAT has poorer sensitivity M–nM but
better spatial resolution. While positron emission tomogra-
phy uses ionizing radiation, PAT uses nonionizing light and
ultrasound. Even at its current level, the sensitivity of PAT is
superior to that of magnetic resonance imaging mM. Fur-
thermore, the sensitivity of PAT can be potentially improved
by increasing the local optical fluence, increasing the optical
absorption cross section of the contrast agent, increasing the
photoacoustic conversion efficiency, increasing signal aver-
aging, and sacrificing the spatial resolution. In comparison to
pure ultrasound imaging, which measures mechanical con-
trast, PAT dominantly measures optical contrast and has
many choices of contrast agents. Ultrasound molecular im-
aging, based on microbubbles, is confined to intravascular
space only. It is worth mentioning that x-ray imaging has not
yet been demonstrated to provide molecular imaging because
of its low sensitivity.
In summary, PAT represents a new paradigm for func-
tional and molecular imaging. Translation to the clinic is
expected to follow the availability of molecular contrast
agents for human use. By combining functional and molecu-
lar imaging in PAT, unprecedentedly high sensitivity and
specificity of cancer diagnosis are expected.
III.E. Photoacoustic tomography of gene expressions
Prediction 5: Deep penetrating high-resolution photoa-
coustic tomography will become a complementary tool to
conventional optical imaging of reporter genes.
Understanding the nature of genes during in vivo devel-
opment and pathogenesis is of significant interest. Such un-
derstanding can be enabled by gene expression imaging, a
form of molecular imaging based on reporter genes. A re-
porter gene is a segment of DNA fused to another gene of
interest. Unlike the contrast-carrying molecular imaging
probe presented in the preceding section, reporter genes must
express into protein products to provide contrast. The two
fused genes, sharing the same promoter, are transcribed into
a single mRNA molecule, which is then translated into fused
proteins. The protein encoded by the reporter gene carries
contrast either directly or through enzymatic reactions. As a
result, a positive contrast in a gene expression image indi-
cates up-regulations of both the reporter gene and the fused
gene. Alternatively, a reporter gene can be used without gene
fusion in order to assay the activity of a particular promoter
in a cell. If the promoter is ubiquitous, a reporter gene can be
used to tag cells. The most widely used conventional optical
imaging of reporter genes include fluorescence imaging of
green fluorescence proteins or their mutants41 and biolumi-
nescence imaging of luciferases.42
Molecular PAT of reporter gene lacZ was demonstrated in
living rats.30 The lacZ gene encodes enzyme -galactosidase.
The enzyme can cleave an optically transparent substrate
5-bromo-4-chloro-3-indolyl--D-galactoside x-gal, yield-
ing a stable dark blue product. The blue product increases
optical absorption and serves as a contrast agent for PAT. So
far, x-gal was injected locally because systemic delivery
through the tail vein turned out to be inefficient.
We hope to collaborate with developers of reporter genes
to construct optical-absorption-based reporter gene systems
that are more suitable for PAT. Because of its high spatial
resolution at depths beyond the reach of pure high-resolution
optical imaging, PAT is expected to become a complemen-
tary tool to conventional optical imaging of reporter genes
in vivo.
III.F. Doppler photoacoustic tomography
Prediction 6: Doppler photoacoustic tomography will pro-
vide imaging of blood flow in vivo with high spatial and
velocity resolution.
The photoacoustic Doppler effect was recently discovered
experimentally.43,44 While the optical Doppler effect involves
light only, the acoustic Doppler effect involves sound only.
By contrast, the photoacoustic Doppler effect involves both
light and sound, resulting from the combination of the pho-
toacoustic and Doppler effects. Here, the photoacoustic wave
undergoes a Doppler shift when the photoacoustic source—
the part of the light absorbing medium generating the pho-
toacoustic wave—has motion relative to the acoustic detec-
tor.
An important application is to image blood flow in vivo
by measuring the photoacoustic Doppler effect due to mov-
ing red blood cells. We coined photoacoustic Doppler flow-
metry PADF for this imaging technology. PADF has poten-
tial advantages over conventional Doppler flowmetry. First,
PAT can image blood vessels at a depth of a few millimeters
with a spatial resolution of tens of micrometers, whereas
Doppler optical coherence tomography can penetrate only
one optical transport mean free path. Second, PADF tracks
light absorbing particles instead of scattering particles. Be-
cause red blood cells have much higher optical absorption
than the background outside blood vessels, PADF should
have low background noise and high sensitivity. By contrast,
acoustic flowmetry suffers from background scattering and
consequently has difficulty measuring slow flows. Third, the
Doppler shift in PADF is nearly independent of the excitation
light, enabling accurate measurement of both speed and di-
rection of flow even at large depths inside an optically scat-
tering medium. In comparison, laser Doppler flowmetry suf-
fers from multiple light scattering, limiting the sensing depth
and obscuring the information of flow direction. Finally,
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PADF is free of speckle artifacts. Therefore, PADF is ex-
pected to break fresh ground for in vivo flow measurement
with high spatial resolution and high velocity sensitivity.
III.G. Photoacoustic tomography of metabolic rate of
oxygen
Prediction 7: Photoacoustic tomography will become the
first single modality that can independently image the meta-
bolic rate of oxygen in vivo using endogenous contrast.
The metabolic rate of oxygen MRO2 quantifies metabo-
lism, which can potentially be directly used to measure hy-
permetabolism, a hallmark of cancer. The MRO2 is defined
as the amount of oxygen consumed in a given tissue region
per unit time per 100 g of tissue or of the organ of interest.
Because in typical physiological conditions, hemoglobin is
the dominant carrier of oxygen the key measure of blood
oxygenation is oxygen saturation of hemoglobin SO2.
PAT can simultaneously image cross sections of blood
vessels, the concentration and oxygenation of hemoglobin, as
well as blood flow in vivo. These four parameters suffice to
quantify oxygen metabolism in tissues and organs. For a
single-vessel system, we have
MRO2  SO2
in
− SO2
out · CHb · Ain · ¯in. 1
Here, Ain is the area of the incoming vessel, ¯in is the mean
flow velocity of blood in the incoming vessel, CHb is the total
concentration of hemoglobin, SO2
in is the SO2 of the incom-
ing vessel to the region of interest, and SO2
out is the SO2 of
the outgoing vessel. While Ain is measured by structural PAT,
CHb and SO2 are measured by multiwavelength functional
PAT; further, ¯in is estimated using Doppler photoacoustic
flowmetry.
It is extremely fortuitous that all independent parameters
in Eq. 1 can be measured by PAT, a single hybrid imaging
modality. By contrast, magnetic resonance imaging detects
only temporal changes in deoxyhemoglobin concentration
instead of absolute values. Equation 1 can be extended to a
multivessel system. Although positron emission tomography
can image MRO2, exogenous radioactive tracers are
required.45,46 Diffuse optical tomography has also been used
to image MRO2 except that a theoretical model or another
technique diffuse correlation imaging is needed to estimate
the blood flow.47,48 Further, both positron emission tomogra-
phy and diffuse optical tomography have low spatial reso-
lution. Therefore, PAT will potentially become the first single
modality that can independently image the metabolic rate of
oxygen in vivo at high spatial resolution without the use of
exogenous contrast agent. It is expected to play a critical role
in metabolism-related biomedical research and clinical diag-
nosis.
III.H. Sentinel lymph node mapping
using photoacoustic tomography
Prediction 1: Sentinel lymph node mapping will become
one of the first niche applications of photoacoustic tomogra-
phy.
For patients with breast cancer but clinically negative ax-
illae, biopsy of the sentinel lymph node SLN—the first
draining nodes—for axillary staging has become a standard
clinical practice. In this conventional method, both optical
dye and radioactive Tc-99 colloids are injected into the breast
tumor. Both contrast agents are accumulated by SLNs. Emis-
sion from radioactivity is first detected to locate approxi-
mately the SLNs. Then, the SLNs are located precisely
through an invasive surgical procedure by visually tracing
the accumulated optical dye such as methylene blue. The
identified SLNs are then resected for pathological examina-
tion. Unfortunately, the surgical procedure has associated
morbidity. A noninvasive method for accurately locating the
SLN in vivo is sought-after because noninvasive diagnostic
methods such as fine needle biopsy could be subsequently
utilized without surgery.
PAT can potentially map the SLN noninvasively with high
spatial resolution in real time, avoiding invasive surgery and
harmful radioactivity. Preliminary data demonstrated that
PAT has both the required penetration depth and spatial res-
olution for SLN mapping.49 PAT can identify whether a node
is sentinel by detecting the accumulated dye because the dye
has high optical absorption contrast. The peak absorption
wavelength of methylene blue dye is 690 nm, which lies near
the optimal optical penetration window. Since the optical
contrast agent has been used in clinical SLN biopsy already,
avoiding FDA approval for a new optical contrast agent can
significantly accelerate the translation of PAT into the
clinic.50 While PAT has broad potential applications, imaging
the SLN is a perfect niche clinical application of PAT with
anticipated high impact on breast axillary staging and man-
agement.
III.I. Multiscale photoacoustic imaging in vivo
with common signal origins
Prediction 9: Multiscale photoacoustic tomography of the
same signal origins in vivo will enable research in multiscale
biology.
Multiscale biology, recognized as the future of biomedical
sciences, needs multiscale imaging. To understand the work-
ings of a whole biological system, components spanning
multiple spatial scales must be integrated. The components
may range from subcellular organelles sub-m scale,
through cells m, to organs cm. To facilitate research in
multiscale biology, we must provide multiscale imaging in
vivo with common signal origins. If the contrast mechanisms
were disconnected among the images of various length
scales, integrating discoveries across the scales would be
challenging.
PAT can provide multiscale imaging in vivo with the same
contrast origins Fig. 3. Our original 50-MHz photoacoustic
microscope can penetrate 3 mm at tens of m resolution.
The image resolution and the penetration limit are scalable
with the ultrasonic frequency within the reach of photons.
On the one hand, the penetration limit can be scaled up to
centimeters, i.e., the hard depth limit. In this case, photoa-
coustic microscopy is scaled to macroscopy. For example,
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employing a 5-MHz ultrasonic transducer and an 804-nm
light source scaled the penetration to 3 cm as shown in Fig.
3a.51 On the other hand, the spatial resolution can be scaled
down to 10 m. Using a focused light beam resulted in
5 m lateral resolution, which is limited by the focal diam-
eter of the excitation light beam. This resolution allows in
vivo imaging of capillaries—the smallest blood vessels—as
shown in Fig. 3c.52 Of course, optical focusing is effective
only within the soft depth limit. Theoretically, the ultimate
spatial resolution is optically diffraction limited, potentially
yielding sub-m resolution in PAT. Therefore, PAT can po-
tentially image as small as organelles and as large as organs
with the same contrast mechanism.
The multiscale or multiresolution capability of PAT is
analogous to that of conventional optical microscopy, where
a single microscope possesses multiple attached objectives,
permitting users to select a magnification factor easily. Such
a capability allows one to image a large region of interest at
a relatively low resolution. Then, one may zoom into a
smaller region of interest with higher resolution to visualize
smaller features while the same contrast mechanism is main-
tained. This scalability is needed because of the tradeoff be-
tween the region of interest and the spatial resolution. Of
course, such scalability is not limited to a single imaging
system. On the contrary, multiple systems can potentially be
used to image at various resolution scales.
PAT is uniquely positioned for multiscale imaging in vivo.
Conventional optical microscopy in various forms is the tool
of choice for microscopic imaging of cells and tissues. It is
capable of offering a wealth of optical contrasts. PAT extends
the depth of conventional optical microscopy beyond the soft
depth limit and provides a continuum for multiscale imaging.
In comparison, conventional clinical imaging modalities
such as x-ray computed tomography, magnetic resonance im-
aging, positron emission tomography, and single photon
emission computed tomography have not been widely used
in microscopic form for various reasons. For example, the
resolution of positron emission tomography is fundamentally
limited by the annihilation range of positrons, on the order of
1 mm. Although ultrasound can achieve microscopic imag-
ing by increasing the frequency from the clinically used
MHz range to GHz range, the contrast reflects mechanical
rather than biochemical properties. Therefore, PAT is ex-
pected to be the first imaging technology, if not the only one
on the horizon, that can potentially span a length scale rang-
ing from organelles to organs while providing consistent bio-
chemical contrast.
III.J. Simultaneous photoacoustic and thermoacoustic
tomography of the breast
Prediction 10: Simultaneous photoacoustic and thermoa-
coustic tomography of the breast will supplement or supplant
x-ray mammography.
While breast cancer remains the leading cause of cancer
death among women, early diagnosis improves survival.
X-ray mammography, the only mass screening tool for de-
tecting nonpalpable breast cancers, has been shown to reduce
breast cancer deaths. However, ionizing radiation is required,
and detecting dense breasts and early-stage tumors is met
with limited sensitivity. In addition, imaging tumors close to
the chest wall is difficult. Therefore, alternative nonionizing
radiation-based screening technologies are needed. So far,
ultrasound imaging has been used as an adjunct to x-ray
mammography, especially in differentiating cystic from solid
breast masses. Magnetic resonance imaging has high sensi-
tivity but variable specificity. It is further limited by its high
cost and use of exogenous contrast agent.
PAT and TAT can be integrated into conventional ultra-
sound imaging to provide multiple complementary contrasts
simultaneously. Three types of images of the breast can be
acquired: 1 structural ultrasound pulse-echo images, 2
functional laser-induced PAT images of concentration and
oxygen saturation of hemoglobin, and 3 radio frequency-
induced TAT images of water and sodium concentrations.
Good optical contrast, related to hallmarks of cancer, be-
tween tumor and normal breast tissues has been observed.53
In TAT, up to 5:1 contrast was observed between tumor and
normal breast tissues.29 In comparison, x-ray contrast among
soft tissues is typically only a few percent. Again, a single
contrast is usually unable to provide accurate diagnosis be-
cause of biological variability. However, the combination of
multiple complementary measures will likely improve the
accuracy.
While compatible with ultrasound imaging, PAT and TAT
are also compatible with each other, sharing the same ultra-
sonic detection system and image reconstruction algorithm.
Integrating PAT with TAT adds significant contrast but does
not add significant costs. PAT and TAT can potentially be
distributed to physicians as an add-on feature to existing
clinical ultrasound imaging systems. While PAT and TAT are
emerging technologies, ultrasonography is a mature clinical
technology. Incorporating PAT and TAT into conventional
ultrasonography will facilitate physicians’ acceptance of the
new technologies.
FIG. 3. a Image acquired with the 5-MHz photoacoustic imaging system
showing the 30 mm penetration limit in chicken breast tissue. Reproduced
with permission Fig. 2 Ref. 51. b Photograph taken with transmission
optical microscopy showing the microvasculature in a nude mouse ear. c
In vivo photoacoustic image of the vasculature acquired with optical-
resolution photoacoustic microscopy. CL: capillary; SG: sebaceous gland.
Reproduced with permission Fig. 3 of Ref. 52.
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In summary, PAT and TAT use nonionizing radiation only
and can be implemented at relatively low cost. It can poten-
tially provide high-resolution, multicontrast imaging of the
breast. Depending on the clinical trial outcome, PAT and TAT
could potentially serve as an adjunct or even replace x-ray
mammography if its sensitivity and specificity are superior.
III.K. Photoacoustic and thermoacoustic tomography
of the brain
Prediction 11: Photoacoustic and thermoacoustic tomog-
raphy will provide low-cost, high-resolution, real-time, and
even bedside functional imaging of the brain.
Existing high-resolution human brain imaging
modalities—including x-ray computed tomography, mag-
netic resonance imaging, and ultrasonography—have limita-
tions. Both x-ray computed tomography and magnetic reso-
nance imaging are expensive and bulky. Further, x-ray
computed tomography uses ionizing radiation, and magnetic
resonance imaging requires a strong magnetic field. There-
fore, it is advantageous to develop an affordable, nonioniz-
ing, high-resolution, and real-time imaging modality that can
be used in operating rooms or at the bedside. Such a system
can be used to monitor brain functions and conditions such
as strokes, head injuries, tumors, and brain infections. In cer-
tain cases, ultrasound brain imaging comes close to meeting
these objectives. Ultrasonography is an established pediatric
brain imaging modality when used before the fontanels are
closed. After the closure of the fontanels, the image quality
degrades significantly because the skull severely attenuates
and distorts ultrasonic waves.
Fortunately, unlike pulse-echo ultrasound imaging, PAT
and TAT involve only one-way ultrasound attenuation and
distortion due to the skull. As demonstrated previously,19 ul-
trasound penetration through small animal skulls is feasible,
and the associated distortions are relatively small. The au-
thor’s group also demonstrated TAT through Rhesus monkey
skulls.54 The extension of PAT and TAT to human brain im-
aging is an area of research. The primary task is to correct
for the phase distortion due to the skull. The skull basically
functions as an irregular lens, whose aberration effect can be
compensated for if the phase distortion can be quantified. A
potential solution is to use geometric measurements of the
skull from x-ray computed tomography or magnetic reso-
nance imaging to predict the phase distortion.
PAT and TAT can provide rich contrasts for high-
resolution structural and functional imaging. As demon-
strated by diffuse optical tomography, near-infrared light can
penetrate through the skull to the cortex and has been used
for functional brain imaging at low spatial resolution. PAT
can potentially provide similar penetration but higher reso-
lution. At an appropriate frequency, radio frequency can pen-
etrate deeper than light. Therefore, TAT can potentially im-
age deeper structures of the brain, while PAT will likely be
used to image cortical functions.
PAT and TAT are also relatively low-cost, real-time, and
portable. In comparison to x-ray computed tomography and
magnetic resonance imaging, ultrasonography is low cost.
PAT and TAT essentially involve a laser or radio frequency
source in addition to the detection components of an ultra-
sound imaging system. Therefore, PAT and TAT can be
implemented at relatively low cost. When ultrasound arrays
are used as in ultrasonography, PAT and TAT can be per-
formed in real time. A standard ultrasound imaging system is
portable and can be used at bedside. With the addition of a
laser or radio frequency source, the entire imaging system
can still be made relatively portable for bedside or operating-
room applications. Again, integrating PAT and TAT into ex-
isting ultrasound imaging systems can potentially accelerate
acceptance of the new technology by physicians.
In summary, the major challenge to PAT and TAT of the
human brain is the phase distortion due to the skull. Correct-
ing the distortion is believed to be a tractable problem.
Therefore, PAT and TAT are expected to provide low-cost,
high-resolution, real-time, and bedside functional imaging of
the brain.
III.L. Low-background thermoacoustic molecular
imaging
Prediction 12: Radio frequency-induced thermoacoustic
tomography will provide high-resolution, high-sensitivity,
and deep-penetrating molecular imaging with the aid of tar-
geted radio frequency contrast agents.
Molecular imaging based on TAT has immense potential.
PAT can provide molecular imaging within the hard depth
limit for optical imaging. By contrast, radio frequency waves
at sufficiently low frequency can penetrate beyond 10 cm as
demonstrated in magnetic resonance imaging. Ultrasound at
an appropriate frequency can travel a similar depth. Conse-
quently, radio frequency-induced TAT can potentially pro-
vide penetration greater than 10 cm. Because low-frequency
radiofrequency waves have low absorption, endogenous ther-
moacoustic signals would be weak, providing a low back-
ground. Such a low background enables highly sensitive de-
tection of any other radio frequency absorbers, which can be
targeted molecular contrast agents. While PAT boasts a
myriad of contrast agents, TAT has none available yet except
the recently tested carbon nanotubes.55 Molecular imaging
TAT is somewhat analogous to low-background positron
emission tomography except that TAT uses nonionizing ra-
diation and provides high spatial resolution. The author’s
group is actively seeking collaborations with chemists to
identify contrast agents for TAT. Once such contrast agents
become available, TAT is expected to avail a new paradigm
of high-resolution, low-background, high-sensitivity, and
deep-penetrating molecular imaging.
IV. SUMMARY
The author believes that PAT and TAT will find broad
applications in both basic research and clinical care. In gen-
eral, it can potentially be applied in tumor studies, where
angiogenesis and hypermetabolism are highly correlated
with cancer aggressiveness; in neuroscience, where oxygen
saturation and concentration of hemoglobin are related to
neural activities; in radiotherapy and chemotherapy of can-
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cer, where hypoxia is responsible for resistance to therapy;
and in trauma evaluation, where optical absorption is associ-
ated with both hemorrhage and edema.
The aforementioned predictions represent the author’s bi-
ased opinions of the most promising prospects of PAT and
TAT. The topics of the 12 predictions are recapitulated as
follows: 1 photoacoustic microscopy of optical absorption
emerging as a mainstream technology, 2 melanoma detec-
tion using photoacoustic microscopy, 3 photoacoustic en-
doscopy, 4 simultaneous functional and molecular photoa-
coustic tomography, 5 photoacoustic tomography of gene
expression, 6 Doppler photoacoustic tomography for flow
measurement, 7 photoacoustic tomography of metabolic
rate of oxygen, 8 photoacoustic mapping of sentinel lymph
nodes, 9 multiscale photoacoustic imaging in vivo with
common signal origins, 10 simultaneous photoacoustic and
thermoacoustic tomography of the breast, 11 photoacoustic
and thermoacoustic tomography of the brain, and 12 low-
background thermoacoustic molecular imaging.
The following specific clinical applications are also worth
pursuing: Demarcation of cancer for Mohs surgery, treatment
planning, and monitoring for laser therapy of port-wine
stains, skin burn imaging to determine the need for skin
graft, intraoperative demarcation of brain tumors, and intra-
operative imaging of brain functions. Undoubtedly, many
more applications will be identified.
While the photoacoustics research community continues
to discover new phenomena and invent new technologies,
several companies are actively commercializing photoacous-
tic tomography. We look forward to seeing the impact of PAT
and TAT on biomedicine.
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